Accelerating the Development of MERS-CoV Technologies

The International Vaccine Institute in South Korea and the Saudi Ministry of Health required strategic and facilitation support to advance a collaborative approach to MERS-CoV vaccine development.

Through consultations with experts in the field, Shift Health helped to set the stage for a symposium that would address mechanistic, preclinical, regulatory and logistical aspects of MERS vaccine development. Engaging an audience of international funders, academics, industry and policymakers, Shift Health facilitated discussions on potential partnership models and synthesized insights from key discussions. Findings were translated into compelling workshop proceedings.

Published in Emerging Infectious Diseases, workshop outcomes aligned players and provided funders with evidence to support investment decisions and accelerate the translation of candidates to the clinic.